AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)
AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)

Cash Flow ABT Quote Abbott Labo

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
NetIncome 1,400 477 2,368
Depreciation 1,353 3,021 3,278
DeferredIncomeT 0 0 0
StockBasedCompe 310 406 477
AccountsReceiva -177 -207 -190
InventoryCS -98 249 -514
AccountsPayable -652 615 747
OtherWorkingCap 0 0 0
OtherNonCashIte 1,653 -249 325
NetCashProvided 3,203 5,570 6,300
InvestmentsInPP -1,121 -1,135 -1,394
AcquisitionsNet -55 -8,437 48
PurchasesOfInve -2,823 -210 -131
SalesMaturities 3,709 129 73
PurchasesOfInta 0 0 0
OtherInvestingA 42 35 48
NetCashUsedForI -248 -9,618 -1,356
DebtIssued 14,934 6,742 4,009
DebtRepayment -12 -8,650 -12,433
CommonStockIssu 0 0 0
CommonStockRepu -522 -117 -238
DividendPaid -1,539 -1,849 -1,974
OtherFinancingA -1,714 -697 245
NetCashProvided 11,147 -5,281 -10,391
NetChangeInCash 13,619 -9,213 -5,563
CashAtBeginning 5,001 18,620 9,407
CashAtEndOfPeri 18,620 9,407 3,844
Abbott Laboratories income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Abbott Laboratories FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.